Nature Reviews Drug Discovery

@NatRevDrugDisc · London · joined 28 Apr 2009

Editorial team of Nature Reviews Drug Discovery.

44 942Followers

469Following

4 172Posts total

56.7KViews on collected posts

Postingan terbaru

Nature Reviews Drug Discovery@NatRevDrugDisc4 Sep

The FDA recently approved the first orexin receptor agonist for narcolepsy https://t.co/xrqJVAIRDr Oveporexton is anticipated to transform the treatment of this sleep disorder, and potential additional applications have led to the class being dubbed the GLP-1s of neuroscience ht 2.8K views · 32 likes · 6 reposts · 1 replies Open on X →

Nature Reviews Drug Discovery@NatRevDrugDisc3 Sep

@NatRevDrugDisc @iu22ie33 And the explanation. 451 views · 0 likes · 0 reposts · 0 replies Open on X →

Nature Reviews Drug Discovery@NatRevDrugDisc3 Sep

For readers interested in the opportunities and pitfalls for CAR-T therapies for autoimmune diseases, here's a recent comprehensive review https://t.co/RNbKBGRrgm https://t.co/b3JOpR4MI7 9.1K views · 167 likes · 49 reposts · 1 replies Open on X →

Nature Reviews Drug Discovery@NatRevDrugDisc2 Sep

Solute carrier membrane transporters: emerging targets in CNS disorders https://t.co/0RpeFcducw https://t.co/YZV9hQkg2I This new Review discusses targeting SLC transporters in neurodegenerative diseases, autism spectrum disorders and epilepsy https://t.co/fFE3YiKZy8 2.9K views · 40 likes · 12 reposts · 1 replies Open on X →

Nature Reviews Drug Discovery@NatRevDrugDisc1 Sep

For readers interested in JAK inhibitors for autoimmmune diseases, such as Roivant's brepocitinib that has just been approved by the FDA for dermatomyositis, here's a review on pharmacological targeting of the JAK-STAT pathway https://t.co/mRjeD1BGoN https://t.co/b3NdcHcPJc https 9.7K views · 167 likes · 50 reposts · 0 replies Open on X →

Nature Reviews Drug Discovery@NatRevDrugDisc28 Aug

Our September issue is live! Read about brain-shuttle biologics, targeting claudins in cancer, agonist antibody-based immunotherapies, autophagy modulation in cancer and more here https://t.co/kWQJeeYbZr https://t.co/AhUat2jkMB 2.1K views · 24 likes · 7 reposts · 0 replies Open on X →

Nature Reviews Drug Discovery@NatRevDrugDisc15 Aug

Andy Blidy Caravello A and Blidy A (2026) A proposed convergent molecular chain linking senescence, cancer, and chronic infection to a correctable failure of dendritic cell instruction. Front. Immunol. 17:1861044. doi: 10.3389/fimmu.2026.1861044 COPYRIGHT © 2026 HYPOTHESIS AND 29.7K views · 30 likes · 10 reposts · 3 replies Open on X →

Dibandingkan akun berukuran sama

7 postingan dari 90 hari terakhir, dibandingkan dengan rentang 10K–100K pengikut. tampil luas, tetapi sedikit penonton yang merespons.

Median tayangan2 873akun ini877median untuk 10K–100K

Jangkauan, %6.39%akun ini3.26%median untuk 10K–100K

Interaksi, %1.47%akun ini2.00%median untuk 10K–100K

Metrik	Akun ini	Median untuk 10K–100K	Rasio
Median tayangan per postingan	2 873	877	3.28×
Jangkauan (tayangan ÷ pengikut)	6.39%	3.26%	1.96×
Tingkat interaksi	1.47%	2.00%	0.74×

Akun lain pada rentang ini → Bandingkan dengan akun lain → Bagaimana tolok ukur ini disusun →

Growth & engagement

How the posts we collected actually performed: views and reaction rate post by post, what the audience did with them, and where the follower count goes.

Views per post

29.7K15 Aug

2.1K28 Aug

9.7K1 Sep

2.9K2 Sep

9.1K3 Sep

451

2.8K4 Sep

Last 7 collected posts, oldest on the left. The scale is logarithmic: one post can outrun the rest a hundred times over.

Engagement rate per post

0.15%15 Aug

1.47%28 Aug

2.25%1 Sep

1.84%2 Sep

2.38%3 Sep

0.00%

1.39%4 Sep

Reactions — likes, reposts, replies and quotes — divided by views. Median for 10K–100K accounts is 2.00%.

What the audience does

Likes58.3%460 in total

Reposts17.0%134 in total

Replies0.8%6 in total

Quotes0.4%3 in total

Bookmarks23.6%186 in total

Share of every reaction we collected for this account. Replies mean argument, reposts mean endorsement, bookmarks mean the post was worth keeping.

The follower curve appears once this account has two daily snapshots — we take one a day, and this one is on its first.